Business
The company offers a virtual care clinic for people with chronic gut issues and will use the funds to expand its reach with providers.
Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, describes the company's AI-enabled software to detect illicit diversion of controlled and non-controlled substances in patient care and the use of AI in its wider portfolio.
The company will use the funds to create and launch new products, expand its network and speed up its growth.
HIMSS24
Brenna Loufek, SaMD regulatory affairs manager at Mayo Clinic, discusses her HIMSS24 session on bringing AI-enabled digital health tools built under research into the clinical setting and what she hopes the audience will gain from the discussion.
The company's FHIR-based platform unifies patient's healthcare data to drive personalized care insights.
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, discusses how Froedtert and Inception Health use genAI, including helping patients with scheduling and navigating healthcare.
The investment comes two years after the California-based company secured $65 million in funding.
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, relays how genAI is impacting various sectors of healthcare and how harnessing the tech will extend human discovery in medicine.
Blockchain technology has the potential to transform healthcare, from securing patient data to reducing the risks for data breaches.
HIMSS24
Trent Sanders, VP of healthcare, U.S., at Kyndryl, previews his upcoming HIMSS24 session in Orlando on Care New England’s digital transformation, Kendryl's role in the project and the benefits of institutional sustainability using innovation.